An observational study on the effects of nadroparin-based and citrate-based continuous venovenous hemofiltration on calcium metabolism

Blood Purification

Volumn 25, Issue 3, 2007, Pages 267-273

  Van Der Voort, Peter H J ^a,b   Postma, Sonja R ^a   Kingma, W Peter ^a   Boerma, E Christiaan ^a   De Heide, Loek J M ^a   Bakker, Andries J ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

Calcium; Critically ill; Hemofiltration; Parathyroid hormone; Vitamin D

Indexed keywords

CALCIUM; CITRIC ACID; NADROPARIN; PARATHYROID HORMONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; HEMOFILTRATION; HUMAN; MAGNESIUM BLOOD LEVEL; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ANTICOAGULANTS; CALCIUM; CALCIUM CITRATE; CHELATING AGENTS; CITRATES; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HEMORRHAGE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; NADROPARIN; PARATHYROID HORMONE; PROSPECTIVE STUDIES; VITAMIN D;

EID: 34447519145     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101853     Document Type: Article

References (15)

1. Mehta RL, Letteri JM: Current status of renal replacement therapy for acute renal failure. A Survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 1999;19:377-382.
2. Bellomo R, Ronco C: Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999;25:781-789.
3. Van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: The struggle between filter clotting and patient hemorrhage. J Am Soc Nephrol 1996;7:145-150.
4. Kutsogiannis DJ, Gibney RTN, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-2367.
5. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate versus heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-265.
6. van der Voort PHJ, Postma SR, Kingma WP, Boerma EC, van Roon EN: Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: a comparison with nadroparin. Int J Artif Organs 2006;29:559-563.
7. Meier-Kriesche H-U, Finkel KW, Gitomer JJ, DuBose TD Jr: Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999;33:e8.
8. Zaloga GP, Sager A, Black KW, Prielipp R: Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 1992;37:226-229.
9. Potts JT: Parathyroid hormone: past and present. J Endocrinol 2005;187:311-325.
10. Nice Data Dictionary: www.stichting-nice.nl
11. Apsner R, Gruber D, Hörl WH, Sunder-Plassmann G: Parathyroid hormone secretion during citrate anticoagulated hemodialysis in acutely ill maintenance hemodialysis patients. Anesth Analg 2004;99:1199-1204.
12. Lind L, Carlstedt F, Rastad J, Stiemström H, Stridsberg M, Ljunggren Ö, Wide L, Larsson A, Hellman P, Ljunghall S: Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 2000;28:93-99.
13. van Oudemans-Straaten HM: Review and guidelines for regional anticoagulation with citrate in continuous hemofiltration. Neth J Crit Care 2004;8:146-156.
14. Van den Berghe G, van Roosbroeck C, Vanhove P, Wouters PJ, de Pourcq L, Bouillon R: Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003;88:4623-4632.
15. Nierman DM, Mechanick JL: Bone hyperresorption is prevalent in chronically critically ill patients. Chest 1998;114:1122-1128.